Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2003
06/26/2003US20030119188 Novel compounds
06/26/2003US20030119082 Fluorescence immunoassay
06/26/2003US20030119070 Complexing ligand, peptide ; displacement of one ligand with another
06/26/2003US20030119065 Peptide and amine examination method using the same
06/26/2003US20030119008 Nucleotides and analogs having photoremovable protecting groups
06/26/2003US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection
06/26/2003US20030118589 Growth factor binding molecules
06/26/2003CA2473890A1 Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation
06/26/2003CA2470026A1 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
06/25/2003EP1320750A2 Methods for identifying agents causing a lethal phenotype
06/25/2003EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof
06/25/2003EP1320595A2 Production process of surfactin
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320538A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-ala- 2-[3-amino-2-oxopyrrolidin-1-yl]propionyl - ala-arg-ala-4-aminophenylacetamide
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP0877807B1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/24/2003US6583265 Cyclosporins
06/24/2003US6582949 Cephaibols: novel antiparasitics from Acremonium tubakii process for their production, and use thereof
06/24/2003US6582899 Methods for identifying agents that cause a lethal phenotype, and agents thereof
06/24/2003US6582700 Linear antigen supporting units
06/24/2003CA2171544C Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
06/19/2003WO2003050542A2 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
06/19/2003WO2003050143A1 Detection and removal of lead using lead-binding proteins
06/19/2003WO2003050140A1 Tumor antigens
06/19/2003WO2003050139A2 Prion inhibiting peptides and derivatives thereof
06/19/2003WO2003050136A2 Peptide t stimulates ctl responses
06/19/2003WO2003049754A1 The use of osteogenic growth peptide in the enhancement of haemopoiesis
06/19/2003WO2003049684A2 Pseudo-antibody constructs
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002040631A3 Dipeptide seryl-histidine and related oligopeptides cleave dna, protein, and a carboxyl ester
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003US20030114642 Peptide
06/19/2003US20030114529 HO-NH-(C=O)-CH2-CH(-CH2-CH(CH3)2)-(C=O)-V-,V=valine or another amino acid connected with an amino acid sequence of 10 or more amino acids; useful for treating diseases caused by cartilage degradation
06/19/2003US20030114386 Anticancer agents, angiogenesis inhibitors
06/19/2003US20030114362 Radical of an amino carboxylic acid bearing a five- membered ring in the peptide backbone; antitumour agents
06/19/2003US20030113819 Carrier peptide and method for delivery of molecules into cells
06/19/2003US20030113749 Interaction trap systems for detecting protein interactions
06/19/2003US20030113733 Transcription factors; nuclear localization peptides; human chorionic gonadotropic hormone(hCG); NF-kappaB/Rel proteins
06/19/2003US20030113714 Binding peptides to polycrystalline semiconductors; detection of bacteriophages; high density magnetic storage; medical imaging; forensics; antitumor agents; anticarcinogenic agents
06/19/2003US20030113711 Protein kinase peptide substrate determination using peptide libraries
06/19/2003US20030113344 Induce an immunogenic response in animals to non-typable Haemophilus influenzae
06/19/2003US20030113339 Methods to improve immunogenicity of antigens and specificity of antibodies
06/19/2003US20030113331 An antagonist specifically binds to a denatured collagens; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
06/19/2003CA2708463A1 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
06/19/2003CA2469274A1 Tumor antigens
06/19/2003CA2467914A1 Prion inhibiting peptides and derivatives thereof
06/18/2003EP1319712A2 Fusion protein having enhanced in vivo activity of erythropoietin
06/18/2003EP1318828A1 Orally administered peptides to ameliorate atherosclerosis
06/18/2003EP0998489B1 A NOVEL ANTIMICROBIAL PEPTIDE ISOLATED FROM $i(PARASILURUS ASOTUS) AND ITS USES
06/18/2003CN1425026A Cyclic hexapeptide derivatives
06/18/2003CN1425025A Daptomycin analogs as antibacterial agents
06/18/2003CN1424322A Trivalent iron porphrin and its derivative-short peptide compound and its synthesis
06/17/2003US6579970 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes.
06/17/2003US6579968 Cyclic peptide of given amino acid sequence; stimulates male erection; less side effects; melanocortin receptor-specific pharmaceutical composition
06/17/2003US6579967 Cyclic peptide of given amino acid sequence; improves binding strength by adding a carbamoyl moiety at N-terminus; useful in determining tissue/cellular expression and in drug screening
06/17/2003US6579696 Comprising diaminobutyric acid having a gamma amino group and amino acid selected from cysteine, alanine and lysine; use in prevention and treatment of sepsis
06/17/2003US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs
06/17/2003CA2251928C Antifungal compositions
06/17/2003CA2106966C Ionic reservoir at electrode surface
06/12/2003WO2003048775A2 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003WO2003048383A2 Effectors of innate immunity
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection
06/12/2003WO2003048178A2 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003WO2003047618A2 Immunotherapeutic methods and systems
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003US20030109675 Therapy for infections; enzyme inhibitors
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109456 TRI-, TETRA-, and penta-peptides having antiangiogenic activity
06/12/2003US20030109455 HEPTA-, OCTA-and nonapeptides having antiangiogenic activity
06/12/2003US20030109454 Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof
06/12/2003US20030109452 Containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
06/12/2003US20030109437 Peptides and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such
06/12/2003US20030109430 Immunoassays for human and canine brain natriuretic peptide
06/12/2003US20030109426 Cyclosporins for the treatment of respiratory diseases
06/12/2003US20030109425 Cyclosporin analogs of the present invention or a pro-drug or pharmaceutically acceptable salt thereof in pharmaceutical compositions for the treatment of asthma and other diseases characterized by airflow obstruction in a subject
06/12/2003US20030109423 Cyclin- dependent kinases (Cdks) are important for driving cells through different phases of the cell cycle and their sequential activation and deactivation are tightly regulated activation of the mitotic Cdk, Cdc2, requires multiple events;
06/12/2003US20030108974 Analyzing antibodies for hepatitis C virus using peptide antigen
06/12/2003US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation
06/12/2003US20030108520 Insecticides; genetic engineered polypeptide
06/12/2003CA2469078A1 Immunotherapeutic methods and systems
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468432A1 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/11/2003EP1317551A2 Human phospholipases and polynucleotides encoding the same
06/11/2003EP1317477A2 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
06/11/2003EP1317476A2 Reagents for cell selection and methods of use
06/11/2003EP1317475A2 Peptides for use in culture media
06/11/2003EP1317287A2 Polymeric conjugates of antitumor agents
06/11/2003EP1317274A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging
06/11/2003EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same
06/11/2003EP1114060B1 Process for producing peptides from biological fluids and peptides obtainable by said process
06/11/2003CN1423656A Lipopeptides as antibacterial agents
06/11/2003CN1423655A Novel lipopeptides as antibacterial agents
06/10/2003US6576611 Methods of reducing atrophy or dysfunction of gut-associated lymphoid tissue
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 423